These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 18950857

  • 1. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
    Qin Y, Zhu H, Jiang B, Li J, Lu X, Li L, Ruan G, Liu Y, Chen S, Huang X.
    Leuk Res; 2009 Mar; 33(3):384-90. PubMed ID: 18950857
    [Abstract] [Full Text] [Related]

  • 2. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
    Qin YZ, Li JL, Zhu HH, Li LD, Chang Y, Hao L, Wang YZ, Jiang B, Lu XJ, Liu YR, Huang XJ, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
    [Abstract] [Full Text] [Related]

  • 3. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M, Palasek I, Pospisil Z, Borsky M, Klabusay M, Brychtova Y, Jurcek T, Jeziskova I, Krejci M, Dvorakova D, Mayer J.
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
    Spanaki A, Perdikogianni C, Linardakis E, Kalmanti M.
    Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
    [Abstract] [Full Text] [Related]

  • 12. [Significance of monitoring WT1 mRNA levels of peripheral blood and bone marrow in acute myeloid leukemia].
    Kitamura K, Nakano Y, Watamoto K, Koga D, Naoe T.
    Rinsho Ketsueki; 2010 Dec; 51(12):1748-55. PubMed ID: 21258184
    [Abstract] [Full Text] [Related]

  • 13. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S, Tanriverdi K, Yavuz S, Disel U, Baslamisli F, Burgut R.
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [Abstract] [Full Text] [Related]

  • 14. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C, Chillón MC, García-Sanz R, Balanzategui A, Sarasquete ME, Alcoceba M, Ramos F, Bernal T, Queizán JA, Peñarrubia MJ, Giraldo P, San Miguel JF, Gonzalez M.
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [Abstract] [Full Text] [Related]

  • 15. [Detection of WT1 expression in bone marrow of acute leukemia patients with real-time quantitative RT-PCR].
    Gu WY, Chen ZX, Cao XS, Hu SY, Zhu J, Wang ZL, Yan F, Wang W, Cen JN, Shen HL, Qian J.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):728-31. PubMed ID: 15730716
    [Abstract] [Full Text] [Related]

  • 16. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
    Lapillonne H, Renneville A, Auvrignon A, Flamant C, Blaise A, Perot C, Lai JL, Ballerini P, Mazingue F, Fasola S, Dehée A, Bellman F, Adam M, Labopin M, Douay L, Leverger G, Preudhomme C, Landman-Parker J.
    J Clin Oncol; 2006 Apr 01; 24(10):1507-15. PubMed ID: 16575000
    [Abstract] [Full Text] [Related]

  • 17. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
    Uzunel M, Ringdén O.
    Bone Marrow Transplant; 2004 Jan 01; 33(1):47-52. PubMed ID: 14704656
    [Abstract] [Full Text] [Related]

  • 18. Elevated levels of WT1 transcripts in bone marrow harvests are associated with a high relapse risk in patients autografted for acute myeloid leukaemia.
    Osborne D, Frost L, Tobal K, Liu Yin JA.
    Bone Marrow Transplant; 2005 Jul 01; 36(1):67-70. PubMed ID: 15908982
    [Abstract] [Full Text] [Related]

  • 19. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
    Barragan E, Pajuelo JC, Ballester S, Fuster O, Cervera J, Moscardo F, Senent L, Such E, Sanz MA, Bolufer P.
    Clin Chim Acta; 2008 Sep 01; 395(1-2):120-3. PubMed ID: 18590714
    [Abstract] [Full Text] [Related]

  • 20. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L, Kalinova M, Ryan J, Quinn F, O'Marcaigh A, Smith O, Browne P, Stary J, McCann SR, Trka J, Lawler M.
    Leukemia; 2006 Feb 01; 20(2):254-63. PubMed ID: 16341043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.